{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:49:57Z","timestamp":1768344597043,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,6]]},"DOI":"10.7759\/cureus.33456","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:00:16Z","timestamp":1673028016000},"source":"Crossref","is-referenced-by-count":2,"title":["From the Deep: Overlap of Neutrophilic Dermatoses Disorders Associated With Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Miguel","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia P","family":"Eus\u00e9bio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Prayce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras EM","year":"2017","unstructured":"Pietras EM. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood. 2017, 130:1693-8. 10.1182\/blood-2017-06-780882","journal-title":"Blood"},{"key":"ref2","unstructured":"Xospata, INN-gilteritinib. (2019). Accessed. 2022 Oct 21: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xospata-epar-product-information_en.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478172","article-title":"FLT3 inhibitor-induced neutrophilic dermatosis","volume":"122","author":"Fathi AT","year":"2013","unstructured":"Fathi AT, Le L, Hasserjian RP, Sadrzadeh H, Levis M, Chen YB. FLT3 inhibitor-induced neutrophilic dermatosis. Blood. 2013, 122:239-42. 10.1182\/blood-2013-01-478172","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.6121","article-title":"FLT3 inhibitor-associated neutrophilic dermatoses","volume":"152","author":"Varadarajan N","year":"2016","unstructured":"Varadarajan N, Boni A, Elder DE, Bagg A, Micheletti R, Perl AE, Rosenbach M. FLT3 inhibitor-associated neutrophilic dermatoses. JAMA Dermatol. 2016, 152:480-2. 10.1001\/jamadermatol.2015.6121","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1766818","article-title":"Sweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor","volume":"10","author":"Paudel A","year":"2020","unstructured":"Paudel A, Dhital R, Areoye G, Basnet S, Tachamo N. Sweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor. J Community Hosp Intern Med Perspect. 2020, 10:275-8. 10.1080\/20009666.2020.1766818","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.636812","article-title":"Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial","volume":"53","author":"Cannas G","year":"2012","unstructured":"Cannas G, Pautas C, Raffoux E, et al.. Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial. Leuk Lymphoma. 2012, 53:1068-76. 10.3109\/10428194.2011.636812","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-00418-2","article-title":"Neutrophilic dermatoses associated with myeloid malignancies","volume":"20","author":"Lepelletier C","year":"2019","unstructured":"Lepelletier C, Bouaziz JD, Rybojad M, Bagot M, Georgin-Lavialle S, Vignon-Pennamen MD. Neutrophilic dermatoses associated with myeloid malignancies. Am J Clin Dermatol. 2019, 20:325-33. 10.1007\/s40257-018-00418-2","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.016","article-title":"From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research","volume":"55","author":"Wallach D","year":"2006","unstructured":"Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006, 55:1066-71. 10.1016\/j.jaad.2006.07.016","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano AV","year":"2016","unstructured":"Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. 2016, 175:882-91. 10.1111\/bjd.14691","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000100","article-title":"Neutrophilic dermatosis: disease mechanism and treatment","volume":"22","author":"Maalouf D","year":"2015","unstructured":"Maalouf D, Battistella M, Bouaziz JD. Neutrophilic dermatosis: disease mechanism and treatment. Curr Opin Hematol. 2015, 22:23-9. 10.1097\/MOH.0000000000000100","journal-title":"Curr Opin Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14102","article-title":"Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome","volume":"174","author":"Haga N","year":"2016","unstructured":"Haga N, Iwata H, Yamaguchi Y, et al.. Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome. Br J Dermatol. 2016, 174:239-41. 10.1111\/bjd.14102","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2003.300101.x","article-title":"The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients","volume":"30","author":"Magro CM","year":"2003","unstructured":"Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol. 2003, 30:1-10. 10.1034\/j.1600-0560.2003.300101.x","journal-title":"J Cutan Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00093.x","article-title":"Acute Crohn's colitis with lobular panniculitis--metastatic Crohn's?","volume":"14","author":"Yosipovitch G","year":"2000","unstructured":"Yosipovitch G, Hodak E, Feinmesser M, David M. Acute Crohn's colitis with lobular panniculitis--metastatic Crohn's?. J Eur Acad Dermatol Venereol. 2000, 14:405-6. 10.1046\/j.1468-3083.2000.00093.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.10.006","article-title":"Neutrophilic panniculitis","volume":"50","author":"Sutra-Loubet C","year":"2004","unstructured":"Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D. Neutrophilic panniculitis. J Am Acad Dermatol. 2004, 50:280-5. 10.1016\/j.jaad.2003.10.006","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232005","article-title":"Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia","volume":"12","author":"Fraticelli P","year":"2019","unstructured":"Fraticelli P, Benfaremo D, Cardinali M, Gabrielli A. Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia. BMJ Case Rep. 2019, 12:10.1136\/bcr-2019-232005","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan SM","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012, 132:2166-70. 10.1038\/jid.2012.130","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1997.20022083.x","article-title":"Pyoderma gangrenosum: a report of 44 cases with follow-up","volume":"137","author":"von den Driesch P","year":"1997","unstructured":"von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997, 137:1000-5.","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus AM","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011, 165:1244-50. 10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su WP","year":"2004","unstructured":"Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004, 43:790-800. 10.1111\/j.1365-4632.2004.02128.x","journal-title":"Int J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis E","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K, et al.. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018, 154:461-6. 10.1001\/jamadermatol.2017.5980","journal-title":"JAMA Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16401","article-title":"The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum","volume":"180","author":"Jockenh\u00f6fer F","year":"2019","unstructured":"Jockenh\u00f6fer F, Wollina U, Salva KA, Benson S, Dissemond J. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol. 2019, 180:615-20. 10.1111\/bjd.16401","journal-title":"Br J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.04.019","article-title":"Comparison of three diagnostic frameworks for pyoderma gangrenosum","volume":"141","author":"Haag C","year":"2021","unstructured":"Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG. Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol. 2021, 141:59-63. 10.1016\/j.jid.2020.04.019","journal-title":"J Invest Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese CA","year":"2022","unstructured":"Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol. 2022, 23:615-34. 10.1007\/s40257-022-00699-8","journal-title":"Am J Clin Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126701-from-the-deep-overlap-of-neutrophilic-dermatoses-disorders-associated-with-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:52Z","timestamp":1707508432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126701-from-the-deep-overlap-of-neutrophilic-dermatoses-disorders-associated-with-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.33456","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,6]]}}}